[HTML][HTML] A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19

E Yekedüz, G Utkan, Y Ürün - European Journal of Cancer, 2020 - Elsevier
Background The COVID-19 pandemic hit all over the world, and cancer patients are more
vulnerable for COVID-19. The mortality rate may increase up to 25% in solid malignancies …

The adverse events of oxycodone in cancer-related pain: a systematic review and meta-analysis of randomized controlled trials

H Ma, Y Liu, L Huang, XT Zeng, SH Jin, GJ Yue, X Tian… - Medicine, 2016 - journals.lww.com
The Adverse Events of Oxycodone in Cancer-Related Pain: A Sy... : Medicine The Adverse
Events of Oxycodone in Cancer-Related Pain: A Systematic Review and Meta-Analysis of …

Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer

JB Chen, XF Kong, F Mu, TY Lu, YY Lu… - Medical Gas …, 2020 - journals.lww.com
Chemotherapy, targeted therapy, and immunotherapy are used against advanced non-small
cell lung cancer. A clinically efficacious method for relieving the adverse events associated …

[Retracted] Effect of Shenqi Fuzheng Injection on Leukopenia and T‐cell Subsets in Patients with Non‐small Cell Lung Cancer Undergoing Radiotherapy

C Wu, Y Liang, F Fu - Evidence‐Based Complementary and …, 2022 - Wiley Online Library
Purpose. The aim of this study is to evaluate the effect of Shenqi fuzheng injection on
leukopenia and T‐cell subsets in patients with non‐small cell lung cancer (NSCLC) …

[HTML][HTML] Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI

KF Yao, M Ma, GY Ding, ZM Li, HL Chen, B Han… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Excess body weight has a positive association with risk of liver cancer, but the gender
difference in the relationship between body mass index and liver cancer risk remains …

The efficacy of erlotinib versus conventional chemotherapy for advanced nonsmall-cell lung cancer: a PRISMA-compliant systematic review with meta-regression and …

H Ma, X Tian, XT Zeng, Y Zhang, Y Wang, F Wang… - Medicine, 2016 - journals.lww.com
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths. Erlotinib is the
first-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), the …

Development of an optimized method for processing peripheral blood mononuclear cells for 1H-nuclear magnetic resonance-based metabolomic profiling

LG Gómez-Archila, M Palomino-Schätzlein… - Plos one, 2021 - journals.plos.org
Human peripheral blood mononuclear cells (PBMCs) are part of the innate and adaptive
immune system, and form a critical interface between both systems. Studying the metabolic …

Risk of serious adverse event and fatal adverse event with molecular target anticancer drugs in cancer patients: A meta-analysis

Z Wang, X Yang, J Wang, S Wang, X Mao… - Journal of Cancer …, 2019 - journals.lww.com
Molecular target anticancer drugs are commonly used in various forms of cancers. It is a
concern that the risk of serious adverse events (SAEs) and fatal adverse events (FAEs) of …

Anticancer effect of isoflavone prunetin on benzo (a) pyrene induced lung cancer mice model

X Yang, VD Seshadri, J Zhang - Pharmacognosy Magazine, 2022 - phcog.com
Background: Cancer, a deadly disease seems to be a major concern for the global medical
field. Controlling the spread of disease is not only a problem for under developed countries …

The efficacy of tyrosine kinase inhibitors combined with chemotherapy for recurrent ovarian cancer: a systematic review and network meta-analysis.

C Haitang, LI Renliang… - Minerva Biotechnology …, 2024 - search.ebscohost.com
INTRODUCTION: Tyrosine kinase inhibitors (TKIs) are beneficial when administrated alone
as adjuvants in women with recurrent ovarian cancer. There is little information regarding …